Patents by Inventor Hyeong Il Kwon

Hyeong Il Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10815284
    Abstract: A fusion protein has the amino acid sequence of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8. A composition having the fusion protein may improve skin wrinkle with increased anti-oxidant activity and skin cell proliferation effect. It can be advantageously used as a raw material of a functional cosmetic having an excellent skin regeneration effect like improvement of skin wrinkles and skin whitening.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: October 27, 2020
    Assignees: NEXGEN BIOTECHNOLOGIES, INC.
    Inventors: Sun Kyo Lee, Tae Hyun Kim, Seong Ran Lee, Han Bong Ryu, Tae Won Choi, Hyeong Il Kwon, Woo Yeon Roh
  • Patent number: 10441632
    Abstract: A method for treating wrinkle or aging on a skin of a subject includes applying to the skin a composition that includes a green fluorescent protein-human epidermal growth factor fusion protein as an effective component. Since the fusion protein has an excellent anti-oxidation activity and a high skin cell proliferation effect, it can be advantageously used as a raw material of functional cosmetics having excellent skin regeneration effect like improvement of skin wrinkles and skin whitening.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: October 15, 2019
    Assignees: NEXGEN BIOTECHNOLOGIES, INC.
    Inventors: Sun Kyo Lee, Seong Ran Lee, Han Bong Ryu, Tae Hyun Kim, Tae Won Choi, Hyeong Il Kwon
  • Publication number: 20190218266
    Abstract: A fusion protein has the amino acid sequence of SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 or SEQ ID NO: 8. A composition having the fusion protein may improve skin wrinkle with increased anti-oxidant activity and skin cell proliferation effect. It can be advantageously used as a raw material of a functional cosmetic having an excellent skin regeneration effect like improvement of skin wrinkles and skin whitening.
    Type: Application
    Filed: August 31, 2017
    Publication date: July 18, 2019
    Inventors: Sun Kyo LEE, Tae Hyun KIM, Seong Ran LEE, Han Bong RYU, Tae Won CHOI, Hyeong Il KWON, Woo Yeon ROH
  • Patent number: 10266817
    Abstract: A botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect has the amino acid sequence of SEQ ID NO: 2, a gene consisting of E. coli (Escherichia coli) codon-optimized nucleotide sequence of SEQ ID NO: 1 for encoding the botulinum toxin-human epidermal growth factor fusion protein, a recombinant vector including the gene, a host cell transformed with the recombinant vector, and a method for producing a botulinum toxin-human epidermal growth factor fusion protein by transforming a host cell with the recombinant vector, and a cosmetic composition for regenerating skin and improving skin wrinkle including, as an effective component, a botulinum toxin-human epidermal growth factor fusion protein, and as the cosmetic composition has an effect of regenerating skin and improving skin wrinkle, it can be advantageously used in future in the field of cosmetics or cosmetic plastic surgery.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: April 23, 2019
    Assignees: NEXGEN BIOTECHNOLOGIES, INC.
    Inventors: Sun Kyo Lee, Han Bong Ryu, Seong Ran Lee, Jong Nam Choi, Tae Won Choi, Tae Hyun Kim, Tae Hwa Jeong, Hyeong Il Kwon
  • Publication number: 20190093095
    Abstract: A botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect has the amino acid sequence of SEQ ID NO: 2, a gene consisting of E. coli (Escherichia coli) codon-optimized nucleotide sequence of SEQ ID NO: 1 for encoding the botulinum toxin-human epidermal growth factor fusion protein, a recombinant vector including the gene, a host cell transformed with the recombinant vector, and a method for producing a botulinum toxin-human epidermal growth factor fusion protein by transforming a host cell with the recombinant vector, and a cosmetic composition for regenerating skin and improving skin wrinkle including, as an effective component, a botulinum toxin-human epidermal growth factor fusion protein, and as the cosmetic composition has an effect of regenerating skin and improving skin wrinkle, it can be advantageously used in future in the field of cosmetics or cosmetic plastic surgery.
    Type: Application
    Filed: July 22, 2016
    Publication date: March 28, 2019
    Inventors: Sun Kyo LEE, Han Bong RYU, Seong Ran LEE, Jong Nam CHOI, Tae Won CHOI, Tae Hyun KIM, Tae Hwa JEONG, Hyeong Il KWON
  • Publication number: 20190022184
    Abstract: A method for treating wrinkle or aging on a skin of a subject includes applying to the skin a composition that includes a green fluorescent protein-human epidermal growth factor fusion protein as an effective component. Since the fusion protein has an excellent anti-oxidation activity and a high skin cell proliferation effect, it can be advantageously used as a raw material of functional cosmetics having excellent skin regeneration effect like improvement of skin wrinkles and skin whitening.
    Type: Application
    Filed: January 25, 2017
    Publication date: January 24, 2019
    Applicant: Nexgen Biotechnologies, Inc.
    Inventors: Sun Kyo LEE, Seong Ran LEE, Han Bong RYU, Tae Hyun KIM, Tae Won CHOI, Hyeong Il KWON
  • Patent number: 10125181
    Abstract: A thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation effect has the amino acid sequence of SEQ ID NO: 2, a gene of E. coli codon-optimized nucleotide sequence of SEQ ID NO: 1 for encoding the human epidermal growth factor-spider venom fusion protein, a recombinant vector including the gene, a host cell transformed with the recombinant vector, and a method for producing in a host cell a human epidermal growth factor-spider venom fusion protein by transforming a host cell with the recombinant vector, and a cosmetic composition for improving skin wrinkle and maintaining skin elasticity including a human epidermal growth factor-spider venom fusion protein, and as the cosmetic composition has excellent thermostability and has an effect of enhancing the activity of improving skin wrinkle and maintaining skin elasticity, it can be advantageously used in future in the field of cosmetics or cosmetic plastic surgery.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: November 13, 2018
    Assignees: NEXGEN BIOTECHNOLOGIES, INC
    Inventors: Sun Kyo Lee, Han Bong Ryu, Seong Ran Lee, Jong Nam Choi, Tae Hyun Kim, Tae Won Choi, Tae Hwa Jeong, Hyeong Il Kwon
  • Publication number: 20180186848
    Abstract: A thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation effect has the amino acid sequence of SEQ ID NO: 2, a gene of E. coli codon-optimized nucleotide sequence of SEQ ID NO: 1 for encoding the human epidermal growth factor-spider venom fusion protein, a recombinant vector including the gene, a host cell transformed with the recombinant vector, and a method for producing in a host cell a human epidermal growth factor-spider venom fusion protein by transforming a host cell with the recombinant vector, and a cosmetic composition for improving skin wrinkle and maintaining skin elasticity including a human epidermal growth factor-spider venom fusion protein, and as the cosmetic composition has excellent thermostability and has an effect of enhancing the activity of improving skin wrinkle and maintaining skin elasticity, it can be advantageously used in future in the field of cosmetics or cosmetic plastic surgery.
    Type: Application
    Filed: July 22, 2016
    Publication date: July 5, 2018
    Inventors: Sun Kyo LEE, Han Bong RYU, Seong Ran LEE, Jong Nam CHOI, Tae Hyun KIM, Tae Won CHOI, Tae Hwa JEONG, Hyeong Il KWON
  • Publication number: 20140012141
    Abstract: A diagnosis-and-display integrated optical tomographic imaging otoscope for examining otitis media. A hollow casing includes an ear specular disposed on a front surface, a display including an LCD disposed on a rear surface, and a manipulating handle on a lower part. An image-photographing part includes a CCD camera inside the casing, and photographs an ear drum image of a patient through the ear specular. A section-photographing part includes a collimator and a galvanometer mirror inside the casing, and photographs section images of the ear drum and a middle ear of the patient. The ear drum image obtained by the image-photographing part and the section images of the ear drum and the middle ear are obtained in a non-incision method by the section-photographing part, and are displayed in real time on the LCD such that desirable images can be stored.
    Type: Application
    Filed: September 9, 2013
    Publication date: January 9, 2014
    Applicant: Kyungpook National University Industry-Academic Cooperation Foundation
    Inventors: Jee Hyun Kim, Nam Hyun Cho, Hyeong Il Kwon, Un Sang Jung, Hyo Sang Jeong